Just submitted my abstract to be considered for short talk at the next #oligonucleotide mtg #OTS2022 Oligonucleotide Therapeutics Society I’m very excited to attend this in-person conference after 2+ yrs and share my latest developments in #aptamer research & #tumor targeting #EGFR #NSCLC BurkeLab

Yeah 🎉 I know how hard you have worked to achieve this result, I’m very proud of you 👏🏼 #WomenInSTEM #workingmama

If you have a minute (I promise it's that quick) - help us out Stemloop, Inc. and take this survey!

Happy to meet again face to face with Montréal crew (and more) 😁. (And hello to Hanadi Sleiman & Masad J. Damha 😁) 🙈☺️

Very excited to join the McGill crew and get dinner together… a great start for this #ots22 Oligonucleotide Therapeutics Society

🚨New paper in Nature Chemistry w/ Phil Holliger joint 1st w/ brill saxophonist & bowtie fan Niklas Freund We describe a polymerase for efficient DNA-templated synthesis of 2’OMe- & MOE-RNA & develop biostable aptamers & RNA-cleaving 2’OMezymes #synbio nature.com/articles/s4155…

This week! BurkeLab alumn Kwaku Tawiah is the featured speaker at the Dec ACES event (Alternative Career Exploration in the Science). Kwaku Dwumah Tawiah

Our latest Nanoscopy for Nanomedicine lab work is out! Understanding aptamer-functionalized nanoparticle multivalency and targeting. Great work of @wth_laura: now your PhD is all out! And as usual fantastic collaboration with our aptamer wizards Donald Burke-Aguero David Porciani sciencedirect.com/science/articl…

End of an era and passing the torch, as Brian takes over the anti-cancer aptamer work and David leaves Mizzou Life Sci Center Mizzou for new challenges Bittersweet/awesome when good friends and long-time collaborators succeed and move on Watch out San Diego! David Porciani Brian Thomas

Discovering relevant proteins is key to identifying druggable targets. The SomaScan® Assay is a 7,000-plex solution (with only 55 µL of serum/plasma): bit.ly/40lCXSD #biomarkers #CancerResearch

Here's Alexandra R. Paul (Alix)'s magnum opus from her PhD now out in Chemical Science - chemical modifications improve aptamers, but how and where should you modify? We can tell you.... pubs.rsc.org/en/content/art…

The FDA recently approved the second RNA aptamer-based drug. Aptamers offer powerful opportunities for drug discovery and development. Read more from SomaLogic experts, Larry Gold and Nebojsa Janjic in Nature Reviews Drug Discovery nature.com/articles/d4157…

In a new paper published in Nature's Scientific Reports, SomaLogic researchers studied the value of protein biomarkers in the early detection of #cancer. Our research team identified 15 blood proteins shared among all cancer types. Read more here: nature.com/articles/s4159…

Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer #MTNA dlvr.it/Sx4hK6

Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer cell.com/molecular-ther…

Want to be one of the first to see all 11,000 protein targets you can access with the NEW SomaScan® 11K Assay? Sign up here: bit.ly/3R379QI #HalfTheHumanProteome #proteomics #biomarkers

Using our SomaScan® Assay and a small blood sample from 5,676 adults, Tony Wyss-Coray’s team Stanford Medicine discovered a groundbreaking “simple and interpretable” method to link organ #aging with disease and mortality risk. #proteomics #biomarkers #Alzheimers

💥Our new paper is officially out! A great collaboration with the aptamer master David Porciani. "Fluorescence Correlation Spectroscopy as a Versatile Method to Define Aptamer-Protein Interactions with Single-Molecule Sensitivity" pubs.acs.org/doi/10.1021/ac…